These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23950920)

  • 1. Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?
    Urbanus AT; van Keep M; Matser AA; Rozenbaum MH; Weegink CJ; van den Hoek A; Prins M; Postma MJ
    PLoS One; 2013; 8(8):e70319. PubMed ID: 23950920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands.
    Eijsink JFH; Al Khayat MNMT; Boersma C; Ter Horst PGJ; Wilschut JC; Postma MJ
    Eur J Health Econ; 2021 Feb; 22(1):75-88. PubMed ID: 33064259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective study.
    McCormick CA; Domegan L; Carty PG; Drew R; McAuliffe FM; O'Donohoe O; White N; Garvey P; O'Grady M; De Gascun CF; McCormick PA
    BJOG; 2022 Jan; 129(2):322-327. PubMed ID: 34706147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands.
    Al Khayat MNMT; Eijsink JFH; Postma MJ; Wilschut JC; van Hulst M
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32825680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare value of implementing hepatitis C screening in the adult general population in Spain.
    Buti M; Domínguez-Hernández R; Casado MÁ; Sabater E; Esteban R
    PLoS One; 2018; 13(11):e0208036. PubMed ID: 30485377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness and population outcomes of general population screening for hepatitis C.
    Coffin PO; Scott JD; Golden MR; Sullivan SD
    Clin Infect Dis; 2012 May; 54(9):1259-71. PubMed ID: 22412061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre.
    Selvapatt N; Ward T; Bailey H; Bennett H; Thorne C; See LM; Tudor-Williams G; Thursz M; McEwan P; Brown A
    J Hepatol; 2015 Oct; 63(4):797-804. PubMed ID: 26024832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States.
    Chaillon A; Rand EB; Reau N; Martin NK
    Clin Infect Dis; 2019 Nov; 69(11):1888-1895. PubMed ID: 30689769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care.
    Tasillo A; Eftekhari Yazdi G; Nolen S; Schillie S; Vellozzi C; Epstein R; Randall L; Salomon JA; Linas BP
    Obstet Gynecol; 2019 Feb; 133(2):289-300. PubMed ID: 30633134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.
    Cipriano LE; Zaric GS; Holodniy M; Bendavid E; Owens DK; Brandeau ML
    PLoS One; 2012; 7(9):e45176. PubMed ID: 23028828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.
    Kim KA; Chung W; Choi HY; Ki M; Jang ES; Jeong SH
    Liver Int; 2019 Jan; 39(1):60-69. PubMed ID: 29998565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting.
    Jülicher P; Galli C
    J Med Econ; 2018 Jan; 21(1):1-10. PubMed ID: 28881157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country.
    Suijkerbuijk AWM; van Hoek AJ; Koopsen J; de Man RA; Mangen MJ; de Melker HE; Polder JJ; de Wit GA; Veldhuijzen IK
    PLoS One; 2018; 13(11):e0207037. PubMed ID: 30408079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened?
    Urbanus AT; van de Laar TJ; van den Hoek A; Zuure FR; Speksnijder AG; Baaten GG; Heijman T; Vriend HJ; Op de Coul EL; Coutinho RA; Prins M
    J Hepatol; 2011 Dec; 55(6):1207-14. PubMed ID: 21703202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis.
    Jülicher P; Chulanov VP; Pimenov NN; Chirkova E; Yankina A; Galli C
    PLoS One; 2019; 14(7):e0219687. PubMed ID: 31310636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective.
    Kim HL; Kim KA; Choi GH; Jang ES; Ki M; Choi HY; Jeong SH
    Clin Mol Hepatol; 2022 Jan; 28(1):91-104. PubMed ID: 34736311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison.
    Ward Z; Mafirakureva N; Stone J; Keevans M; Betts-Symonds G; Crowley D; McHugh T; Avramovic G; Lambert JS; Vickerman P
    Int J Drug Policy; 2021 Oct; 96():103394. PubMed ID: 34412938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States.
    Chaillon A; Wynn A; Kushner T; Reau N; Martin NK
    Clin Infect Dis; 2021 Nov; 73(9):e3355-e3357. PubMed ID: 32282879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic model of a birth cohort screening program for hepatitis C virus.
    McGarry LJ; Pawar VS; Panchmatia HR; Rubin JL; Davis GL; Younossi ZM; Capretta JC; O'Grady MJ; Weinstein MC
    Hepatology; 2012 May; 55(5):1344-55. PubMed ID: 22135116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.